1 documents found
Information × Registration Number 0115U000672, R & D request Title Many centers, open-label study - continued, assess the safety and efficacy of long-term treatment with BIIB019 (Daklizumab high efficiency performance (SAC CPSU)) as monoteratsiyi in patients with multiple sclerosis who completed the study 205MS301 Head Lytvynenko Nataliia , Доктор медичних наук Registration Date 02-03-2015 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
Many centers, open-label study - continued, assess the safety and efficacy of long-term treatment with BIIB019 (Daklizumab high efficiency performance (SAC CPSU)) as monoteratsiyi in patients with multiple sclerosis who completed the study 205MS301
Head: Lytvynenko Nataliia . Many centers, open-label study - continued, assess the safety and efficacy of long-term treatment with BIIB019 (Daklizumab high efficiency performance (SAC CPSU)) as monoteratsiyi in patients with multiple sclerosis who completed the study 205MS301. Ukrainian medical stomatological Academy. № 0115U000672
1 documents found

Updated: 2026-03-26


Роздрукувати цю сторінку